Digital mobility outcomes to describe real-world walking during recovery from a hip fracture: the Mobilise-D perspective

The observed variation in walking amount and pace and pattern across recovery phases indicate that DMOs provide a granular analysis of real-world mobility of hip fracture survivors. When confirmed by longitudinal analyses, including results on minimal important differences, the use of selected DMOs will provide a novel approach for monitoring, predictive modelling, prognosis, stratification, and evaluation of clinical trials and hip fracture services.

Authors

Institutions

Publication Details

Journal
European Geriatric Medicine
Published
2026-01-03
DOI
https://doi.org/10.1007/s41999-025-01391-w
Citations
1
Primary Topic
Hip and Femur Fractures
Type
article
Field-Weighted Citation Impact
39.15
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Digital mobility outcomes to describe real-world walking during recovery from a hip fracture: the Mobilise-D perspective

Daniel Rooks, Andrea Cereatti, Ingvild Saltvedt, Tobias Eckert et al.
1 citations
European Geriatric Medicine
Hip and Femur Fractures
39.15
article

Digital mobility outcomes to describe real-world walking during recovery from a hip fracture: the Mobilise-D perspective

Daniel Rooks, Andrea Cereatti, Ingvild Saltvedt, Tobias Eckert, Ram R. Miller, Niki Brenner, Valérie Driss, Joren Buekers, Anna Marcuzzi, Lars Gunnar Johnsen, Silvia Del Din, Beatrix Vereijken, Jochen Klenk, Monika Engdal, Jorunn L. Helbostad, Blain Hubert, Paula Alvarez, David Singleton, Martin Aursand Berge, Judith García-Aymerich, C Jansen, Clemens Becker, Laura Delgado-Ortiz, Trine Strøm, Sarah Koch, Brian Caulfield, Lene Bergendal Solberg, Lynn Rochester
article en
1 citations

Abstract

The observed variation in walking amount and pace and pattern across recovery phases indicate that DMOs provide a granular analysis of real-world mobility of hip fracture survivors. When confirmed by longitudinal analyses, including results on minimal important differences, the use of selected DMOs will provide a novel approach for monitoring, predictive modelling, prognosis, stratification, and evaluation of clinical trials and hip fracture services.

European Geriatric MedicineVol. 17(1)
University College Dublin (IE), Oslo University Hospital (NO), Novartis (Switzerland) (CH), Inserm (FR), Universitat Pompeu Fabra (ES), Politecnico di Torino (IT), University of Basel (CH), Universität Ulm (DE), Université de Montpellier (FR), Norwegian University of Science and Technology (NO), Heidelberg University (DE), Newcastle upon Tyne Hospitals NHS Foundation Trust (GB), Robert Bosch Stiftung (DE), University Hospital Heidelberg (DE), Centre Hospitalier Universitaire de Montpellier (FR), Zimmer Biomet (Germany) (DE), Clinical Investigation Center Plurithematic Tours (FR), Clinique du Millénaire (FR), St Olav's University Hospital (NO), Novartis (United States) (US), NIHR Newcastle Biomedical Research Centre (GB), Institute for Neurosciences of Montpellier (FR), Barcelona Institute for Global Health (ES), Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES), Newcastle University (GB), Heidelberg University (US)
No poverty
Openalex Percentile: Top 2%
Hip and Femur Fractures
39.15
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.